Division of Regenerative Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Centre (VRC), 3000 Leuven, Belgium.
Cell Metab. 2016 Apr 12;23(4):571-3. doi: 10.1016/j.cmet.2016.03.012.
Unraveling the mechanism VEGF-receptors modulating metabolism has therapeutic implications. In this issue, Robciuc et al. (2016) demonstrate that VEGF-B, by displacing VEGF-A from VEGFR1 and activating VEGFR2, increases adipose tissue vascularity, improves insulin sensitivity, diminishes obesity, and alleviates metabolic syndrome.
阐明 VEGF 受体调节代谢的机制具有治疗意义。在本期杂志中,Robciuc 等人(2016 年)表明,VEGF-B 通过从 VEGFR1 上置换 VEGF-A 并激活 VEGFR2,增加脂肪组织的血管生成,改善胰岛素敏感性,减少肥胖,并缓解代谢综合征。